Naveenkrishna Tarur, Principal Consultant Life Sciences Domain Consulting Group, Infosys, elaborates on the need to establish a credible roadmap for serialisation programme by pharma companies ...

Although there is a growing global trend among major pharmaceutical companies to introduce serialisation production line equipment, I would estimate, based on Mettler Toledo?s experience, that less ...

Product-level serialisation has historically been associated with compliance mandates within highly regulated industries such as pharmaceuticals, medical devices, and tobacco. Its central premise was ...

The complexity within pharmaceutical supply chains is exceptional, with ingredients and medicines often crossing the borders of multiple countries before reaching the end consumer. Driven by patient ...

Recent research shows that the pharmaceutical industry is intensifying efforts to combat counterfeit drugs, which account for up to 30% of medicines sold globally. In a major step toward securing ...

Beyond serialisation – the use of on-dose authentication to protect patients and brands from the rising threat of counterfeit drugs With the World Health Organisation reporting that over half of all ...

Arjun Guha Thakurta, Director – Operations, Life Science Consulting, (a Convalgroup Company) gives an insight about the impact of serialisation programmes on pharma companies Serialisation regulations ...

Pharmaceutical manufacturers will be-and are already&mdashfacing enormous challenges to implement the serialization regulations within the given timeframe. Packaging machinery suppliers describe how ...

The UK's new energy industry champion, Great British Energy (GBE) is preparing a competitive process to support key ...